The breakneck pace of consolidation continued in 2017, significantly reducing the pool of Big 100 companies, as cash-laden companies scooped up smaller firms. The medical device industry may not be keeping pace with initial public offerings in biotech, but medtech is holding its own when comes to mergers and acquisitions, according to industry watchers. Boston […]
Medtech entrepreneurs agree that it’s still tough to find funding at the Series A level. Here’s their advice about how to find it. Bill Evans Competition for medtech venture investing is fierce, at the same time that traditional investors pull back from the space. To get to the bottom of what’s going on, I reached […]
Ask any early-stage medtech or digital health entrepreneur, and they’ll tell you how tough it is. There’s tremendous competition for venture investing, coupled with a pullback by previously traditional investors in this space. Bill Evans While venture investment in medtech and digital health has recovered since the financial crisis of a decade ago — setting […]
Big data and artificial intelligence will have the greatest impact in the health-tech industry in the year ahead, according to a survey released yesterday. The survey, performed by Silicon Valley Bank, polled 122 founders, execs and investors in health care technology companies about the biggest challenges, most promising technology and biggest growth sectors in the […]
September 24, 2014 by Brad Perriello
July 31, 2014 by Arezu Sarvestani
The funding environment for medical device startups isn’t a pretty scene, but there is a ray of sunshine through the gloom: lack of FDA approval is no longer a deal-breaker for a big exit.
In 2013 a few medtech companies managed "big exit M&A" deals (those worth $50 million or more) without having reached the FDA’s brass ring, according to a new report from Silicon Valley Bank.
If you’re a startup medical device company looking for an angel, it pays to go west, according to a new report.
The most active angel investors for medical device, diagnostics, biotechnology and other life science companies appear to be clustering, according to a new report by Silicon Valley Bank and the Angel Resource Institute.
The National Venture Capital Assn. is spearheading a drive to get a bill through the U.S. Senate that would make it easier for small companies to raise money by going public.
The "IPO On Ramp" measure would ease the regulatory requirements for IPOs and temporarily reduce the reporting burdens imposed by the Sarbanes-Oxley Act.